Is It Time to Replace Pharmaceuticals with Medical Cannabis?

Patients in Malta living with chronic pain, anxiety and sleep disorders are often prescribed strong pharmaceuticals such as morphine, tramadol, benzodiazepines and zolpidem. While common in standard medical care, these medications carry significant risks — dependence, tolerance, cognitive impairment and withdrawal.

At The Pain Clinic, we believe that medical cannabis deserves to be considered as a legitimate, evidence-based option — especially for patients who haven’t found relief through conventional treatment, or who experience unacceptable adverse effects.

This isn’t about abandoning all other therapies. It’s about acknowledging that medical cannabis is a medication, supported by growing evidence, that can be prescribed safely and responsibly by trained clinicians.

Understanding the Risks of Standard Treatments

Chronic pain

Opioids such as morphine and tramadol pose a high risk of:

• Addiction
• Tolerance
• Sedation
• Constipation
• Respiratory depression

These medications can be life-saving in acute settings — but are associated with harm in long-term use.

Anxiety

Benzodiazepines are widely prescribed but associated with:

• Memory problems
• Dependence
• Cognitive impairment
• Difficult withdrawal syndromes

Insomnia

Sleep medications like zolpidem (Stilnox) can cause:

• Next-day drowsiness
• Impaired memory
• Dependence
• Rebound insomnia

Despite these risks, many long-term patients — including those who have completed detox programmes — continue to be prescribed these medications, yet may be denied access to cannabis, which may offer a safer long-term alternative.

What Medical Cannabis Really Is — and What It Is Not

One of the main barriers to progress is misconception. Many people, including some healthcare professionals, still associate cannabis with recreational use, addiction and a lack of control. This view is outdated.

Evidence for Chronic Pain Relief — Strong and Consistent

A landmark report by the National Academies of Sciences, Engineering, and Medicine (2017) confirmed substantial evidence that cannabis is effective for chronic pain in adults.

Best recent studies (2024–2025)

Medical cannabis is increasingly recognised internationally as a legitimate, evidence-supported treatment for chronic pain — often enabling patients to safely reduce opioids.

CBD for Anxiety — A Safer Alternative to Benzodiazepines

CBD has been widely studied as a non-addictive, non-sedating anxiolytic.

CBD may help patients stabilise anxiety without sedation, addiction or withdrawal — a key advantage over benzodiazepines.

CBD & CBN for Sleep — Promising Benefits for Insomnia

CBD and CBN may improve sleep by reducing pain, anxiety, hyperarousal and inflammation.

CBD and CBN are especially suited for insomnia linked to pain, anxiety, or stress — without the risks associated with zolpidem.

A Missed Opportunity for Patients in Malta

Many patients who struggle with substance use are denied access to medical cannabis — yet continue to receive high-risk medications such as opioids and benzodiazepines. From a public health perspective, that’s contradictory.

Patients deserve:

• Compassionate care
• Modern evidence-based options
• Reduced harm — not increased risk

Medical cannabis isn’t a cure-all. But it’s a reasonable therapeutic option that can be prescribed responsibly.

Real Patients. Real Results.

Patients at The Pain Clinic often report:

• Reduced chronic pain
• Fewer side effects
• Better emotional stability
• Improved sleep
• Reduced reliance on opioids or sedatives

Their experience reflects the emerging scientific evidence.

A Balanced, Clinical Approach

Medical cannabis should be seen as one tool in a physician’s toolkit — not a political argument, not a shortcut and not a recreational suggestion.

Let’s Talk About Safer Alternatives

If you’re ready to explore a treatment that’s safer, more natural and more sustainable, we’re here to guide you.